Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1969 1
1970 2
1971 1
1972 3
1973 1
1975 1
1976 3
1978 1
1979 2
1980 2
1981 3
1982 1
1983 3
1984 4
1985 12
1986 5
1987 8
1988 3
1989 5
1990 7
1991 6
1992 9
1993 6
1994 4
1995 10
1996 16
1997 16
1998 16
1999 13
2000 13
2001 19
2002 10
2003 4
2004 13
2005 16
2006 14
2007 13
2008 12
2009 20
2010 14
2011 23
2012 23
2013 33
2014 36
2015 37
2016 24
2017 21
2018 32
2019 44
2020 49
2021 35
2022 36
2023 28
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

648 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypotrichosis 3"
Page 1
Common causes of hair loss - clinical manifestations, trichoscopy and therapy.
Alessandrini A, Bruni F, Piraccini BM, Starace M. Alessandrini A, et al. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):629-640. doi: 10.1111/jdv.17079. Epub 2021 Jan 8. J Eur Acad Dermatol Venereol. 2021. PMID: 33290611 Review.
Many treatments are available, and a prompt diagnosis is very important for the prognosis....
Many treatments are available, and a prompt diagnosis is very important for the prognosis....
Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review.
Drake L, Reyes-Hadsall S, Martinez J, Heinrich C, Huang K, Mostaghimi A. Drake L, et al. JAMA Dermatol. 2023 Jan 1;159(1):79-86. doi: 10.1001/jamadermatol.2022.4867. JAMA Dermatol. 2023. PMID: 36449274
Quality was assessed with Oxford Centre for Evidence Based Medicine criteria. Outcomes of interest were disease course, both objectively and subjectively measured. Data were evaluated from January 3 to 11, 2022. ...Kimchi and cheonggukjang, vitamin D3, and Forti5 had low-q …
Quality was assessed with Oxford Centre for Evidence Based Medicine criteria. Outcomes of interest were disease course, both objectiv …
Pediatric androgenetic alopecia: A review.
Griggs J, Burroway B, Tosti A. Griggs J, et al. J Am Acad Dermatol. 2021 Nov;85(5):1267-1273. doi: 10.1016/j.jaad.2019.08.018. Epub 2019 Aug 12. J Am Acad Dermatol. 2021. PMID: 31415838 Review.
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review.
Diotallevi F, Campanati A, Martina E, Radi G, Paolinelli M, Marani A, Molinelli E, Candelora M, Taus M, Galeazzi T, Nicolai A, Offidani A. Diotallevi F, et al. Nutrients. 2022 Jan 29;14(3):591. doi: 10.3390/nu14030591. Nutrients. 2022. PMID: 35276950 Free PMC article. Review.
However, owing to the complexity of immune-mediated skin disease clinical course and breadth and variability of human nutrition, their correlation still remains an open debate in literature. It is therefore important for dermatologists to be aware about the scientific basi …
However, owing to the complexity of immune-mediated skin disease clinical course and breadth and variability of human nutrition, thei …
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Guttman-Yassky E, Renert-Yuval Y, Bares J, Chima M, Hawkes JE, Gilleaudeau P, Sullivan-Whalen M, Singer GK, Garcet S, Pavel AB, Lebwohl MG, Krueger JG. Guttman-Yassky E, et al. Allergy. 2022 Mar;77(3):897-906. doi: 10.1111/all.15071. Epub 2021 Sep 6. Allergy. 2022. PMID: 34460948 Free PMC article. Clinical Trial.
After 48 weeks of dupilumab treatment, 32.5%, 22.5% and 15% of patients achieved SALT(30) /SALT(50) /SALT(75) improvement, respectively, while in patients with baseline IgE 200 IU/ml response rates increased to 53.8%, 46.2%, and 38.5%, respectively. Moreover, baseline IgE pred …
After 48 weeks of dupilumab treatment, 32.5%, 22.5% and 15% of patients achieved SALT(30) /SALT(50) /SALT(75) improvement, respectively, whi …
Frontal Fibrosing Alopecia - a review and a practical guide for clinicians.
Kępińska K, Jałowska M, Bowszyc-Dmochowska M. Kępińska K, et al. Ann Agric Environ Med. 2022 Jun 24;29(2):169-184. doi: 10.26444/aaem/141324. Epub 2021 Aug 31. Ann Agric Environ Med. 2022. PMID: 35767748 Free article. Review.
Clinical presentation of FFA can be divided into 3 specific patterns, each with a different prognosis. Diagnosis is usually made clinically with the use of trichoscopy; however, scalp biopsy remains the gold standard. ...
Clinical presentation of FFA can be divided into 3 specific patterns, each with a different prognosis. Diagnosis is usually made clin …
Microneedling in androgenetic alopecia; comparing two different depths of microneedles.
Faghihi G, Nabavinejad S, Mokhtari F, Fatemi Naeini F, Iraji F. Faghihi G, et al. J Cosmet Dermatol. 2021 Apr;20(4):1241-1247. doi: 10.1111/jocd.13714. Epub 2020 Sep 29. J Cosmet Dermatol. 2021. PMID: 32897622

RESULTS: Compared with the baseline, a significant increase in hair count and hair thickness was observed in all three groups after completion of the treatment course (P < .05). The mean rise in hair count (P = .017) and hair thickness (P = .007) was significantly great

…
RESULTS: Compared with the baseline, a significant increase in hair count and hair thickness was observed in all three groups after completi …
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O, Senna MM, Sinclair R, Ito T, Dutronc Y, Lin CY, Yu G, Chiasserini C, McCollam J, Wu WS, King B. Kwon O, et al. Am J Clin Dermatol. 2023 May;24(3):443-451. doi: 10.1007/s40257-023-00764-w. Epub 2023 Mar 1. Am J Clin Dermatol. 2023. PMID: 36855020 Free PMC article. Clinical Trial.
Long-term therapy is important in AA, and hair regrowth can take longer in some patients with severe disease. Therefore, we assessed outcomes from a longer course of therapy. In this study, we report the results after 52 weeks of continuous treatment with baricitinib 4 mg …
Long-term therapy is important in AA, and hair regrowth can take longer in some patients with severe disease. Therefore, we assessed outcome …
Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis.
Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Lee HH, et al. J Am Acad Dermatol. 2020 Mar;82(3):675-682. doi: 10.1016/j.jaad.2019.08.032. Epub 2019 Aug 19. J Am Acad Dermatol. 2020. PMID: 31437543
Previous studies found conflicting results about AA epidemiology. OBJECTIVE: To determine the prevalence, incidence, and predictors of AA, alopecia totalis, alopecia ophiasis, and alopecia universalis. ...
Previous studies found conflicting results about AA epidemiology. OBJECTIVE: To determine the prevalence, incidence, and predictors o …
648 results